Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barb Thorne

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|May 12, 2009
Non-Antibody Protein Therapeutics Development & Production--IBC Conference. Successful strategies for bringing protein therapeutics to marketBarb Thorne
Advances in Biochemical Engineering/Biotechnology|March 15, 2017
Gene TherapyBarb Thorne, Ryan Takeya, Francesca Vitelli, et al.
Gene Therapy|August 17, 2023
Safety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseasesDuncan J Stewart, Albert Gianchetti, Dawn Byrnes, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|May 12, 2009
Non-Antibody Protein Therapeutics Development & Production--IBC Conference. Successful strategies for bringing protein therapeutics to marketBarb Thorne
Advances in Biochemical Engineering/Biotechnology|March 15, 2017
Gene TherapyBarb Thorne, Ryan Takeya, Francesca Vitelli, et al.
Gene Therapy|August 17, 2023
Safety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseasesDuncan J Stewart, Albert Gianchetti, Dawn Byrnes, et al.
Pageof 1